|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Gloom. Doom. But the sky isn’t falling – yet. Sagging, maybe. Outside the workplace, we talk about negative energies, how they are generated, how we feel them, and their minus impact on our lives. What ...
Lower TAVR sales due to recall of Lotus valves within the European and other key markets is likely to mar Boston Scientific's (BSX) top-line performance in Q2.